Detalles de la búsqueda
1.
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real-world data.
Liver Int
; 43(8): 1803-1812, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37452505
2.
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation.
Cancer Immunol Immunother
; 71(4): 865-874, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34462870
3.
Role of next-generation genomic sequencing in targeted agents repositioning for pancreaticoduodenal cancer patients.
Pancreatology
; 2021 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-33896692
4.
Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer.
Int J Mol Sci
; 19(2)2018 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29389861
5.
Molecular screening with liquid biopsy for anti-EGFR retreatment in metastatic colorectal cancer: preliminary data from the randomized phase 2 PARERE trial.
Front Oncol
; 13: 1307545, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38406172
6.
Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients.
Target Oncol
; 18(1): 139-145, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36689074
7.
Home-Based Management of Patients With Cancer Experiencing Treatment-Induced Toxicities With a Nurse-Led Telephone Triage (the NTT Study).
JCO Oncol Pract
; 18(1): e20-e27, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34242052
8.
Interleukin-8 in Colorectal Cancer: A Systematic Review and Meta-Analysis of Its Potential Role as a Prognostic Biomarker.
Biomedicines
; 10(10)2022 Oct 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36289899
9.
Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma.
Eur J Cancer
; 171: 232-241, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35749808
10.
Molecular profile and its clinical impact of IDH1 mutated versus IDH1 wild type intrahepatic cholangiocarcinoma.
Sci Rep
; 12(1): 18775, 2022 11 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36335135
11.
Pralsetinib in RET fusion-positive non-small-cell lung cancer: A real-world data (RWD) analysis from the Italian expanded access program (EAP).
Lung Cancer
; 174: 118-124, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36379124
12.
Next-generation sequencing analysis of cholangiocarcinoma identifies distinct IDH1-mutated clusters.
Eur J Cancer
; 175: 299-310, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36182816
13.
State-of-the-Art of Monoclonal Antibodies for the Treatment of Gastric Cancer.
Biologics
; 15: 451-462, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34764633
14.
Comparing immunotherapies to other frequently used treatments of gastric cancer.
Expert Rev Clin Pharmacol
; 14(10): 1221-1232, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34114518
15.
Cholangiocarcinoma: new perspectives for new horizons.
Expert Rev Gastroenterol Hepatol
; 15(12): 1367-1383, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34669536
16.
Rationale and Study Design of the PARERE Trial: Randomized phase II Study of Panitumumab Re-Treatment Followed by Regorafenib Versus the Reverse Sequence in RAS and BRAF Wild-Type Chemo-Refractory Metastatic Colorectal Cancer Patients.
Clin Colorectal Cancer
; 20(4): 314-317, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34364814
17.
Case Report: A Metabolic Complete Response to Upfront Osimertinib in a Smoker Non-Small Cell Lung Cancer Patient Harbouring EGFR G719A/V769M Complex Mutation.
Onco Targets Ther
; 13: 12027-12031, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33262603
18.
Plasma IL8 Is a Biomarker for TAK1 Activation and Predicts Resistance to Nanoliposomal Irinotecan in Patients with Gemcitabine-Refractory Pancreatic Cancer.
Clin Cancer Res
; 26(17): 4661-4669, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32532788
19.
From Genetic Alterations to Tumor Microenvironment: The Ariadne's String in Pancreatic Cancer.
Cells
; 9(2)2020 01 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32012917
20.
Modulating TAK1 Expression Inhibits YAP and TAZ Oncogenic Functions in Pancreatic Cancer.
Mol Cancer Ther
; 19(1): 247-257, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31562256